These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3117632)

  • 1. Immune status of hemophilia patients treated with concentrates. Study of 20 cases.
    Callea V; Trapani Lombardo V; Brugiatelli M; Latella C; Fragomeno C; Liotta C; Oliva BM; Piromalli A; Neri A
    Haematologica; 1987; 72(4):323-8. PubMed ID: 3117632
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic status, granulocyte chemotaxis and antibodies to HTLVIII/LAV in haemophiliacs treated with clotting factor concentrates.
    Gamba G; Ippoliti G; Bajani G; Ricevuti G; Mazzone A; Badarida G; Gobbi P; Geroldi D; Ascari E
    Haematologica; 1987; 72(2):129-35. PubMed ID: 3040550
    [No Abstract]   [Full Text] [Related]  

  • 3. Fighting HIV: a clue from hemophilia.
    Science; 1994 Jan; 263(5143):27. PubMed ID: 8272864
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for hemophilia care.
    Mehta P; Saba H; Lian E; Davis J; Cumming W; Barrett D; Sandler E; Kalen V; Kao KJ; Reiter W
    J Fla Med Assoc; 1991 Apr; 78(4):222-4. PubMed ID: 2056300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in Leu 2+ Leu 7+ lymphocytes in HIV 1-seropositive patients with hemophilia repeatedly treated with clotting factor concentrates.
    Kaplan J; Sarnaik I; Lusher J
    Clin Immunol Immunopathol; 1988 Mar; 46(3):337-41. PubMed ID: 3257429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-antibody seroconversions in Dutch haemophiliacs using heat-treated and non heat-treated coagulation factor concentrates.
    Wolfs TF; Breederveld C; Krone WJ; vd Hoek L; Bakker M; Smit L; Goudsmit J
    Thromb Haemost; 1988 Jun; 59(3):396-9. PubMed ID: 3142077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clotting factor concentrates].
    Barthels M; Oldenburg J
    Hamostaseologie; 2008 Dec; 28(5):387-99. PubMed ID: 19132169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease.
    Josephson CD; Abshire TC
    Best Pract Res Clin Haematol; 2006; 19(1):35-49. PubMed ID: 16377540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors of life.
    Carlisle D
    Nurs Times; 1997 Feb 5-11; 93(6):56-7. PubMed ID: 9095935
    [No Abstract]   [Full Text] [Related]  

  • 10. Need for randomized trials in hemophilia.
    Mannucci PM
    J Thromb Haemost; 2006 Mar; 4(3):501-2. PubMed ID: 16460428
    [No Abstract]   [Full Text] [Related]  

  • 11. Can evidence harm? Certainly not hemophilia treatment and community.
    Iorio A; Stobart K; Bolton-Maggs P
    J Thromb Haemost; 2006 Mar; 4(3):505-6. PubMed ID: 16460430
    [No Abstract]   [Full Text] [Related]  

  • 12. The use of blood fractions in coagulation disorders.
    Biggs R
    Br J Haematol; 1969 Dec; 17(6):604. PubMed ID: 5357747
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemophilia replacement products, clinical trials: inhibitors and pharmacokinetics-can they be done?
    Aledort LM
    J Thromb Haemost; 2004 Oct; 2(10):1855-6. PubMed ID: 15456506
    [No Abstract]   [Full Text] [Related]  

  • 14. The improved factor concentrate.
    Lillicrap D
    Hamostaseologie; 2009 Jan; 29(1):71-3. PubMed ID: 19151851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Procoagulant hemoderivatives, hemophilia and immunity].
    Traldi A; Davoli PG; Gajo GB; Tegon G; De Biasi E; Dal Canton A; Cavallin F; Gavioli A; Prosdocimo MT
    Haematologica; 1984; 69(6):771-3. PubMed ID: 6441758
    [No Abstract]   [Full Text] [Related]  

  • 16. Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee.
    Kasper CK; Lusher JM
    Transfusion; 1993 May; 33(5):422-34. PubMed ID: 8488548
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hemophilia with prothrombin-complex concentrates.
    Krauss JS
    N Engl J Med; 1980 Dec; 303(24):1418. PubMed ID: 7432394
    [No Abstract]   [Full Text] [Related]  

  • 18. Can we consider discontinuing primary prophylaxis in adults with severe haemophilia?
    Fischer K
    Haemophilia; 2008 Jul; 14 Suppl 4():10. PubMed ID: 18494687
    [No Abstract]   [Full Text] [Related]  

  • 19. Replacement therapy with virus-inactivated clotting factor concentrates in patients with severe hemophilia in Heidelberg.
    Zimmermann R; Uhle C; Huth-Kühne A
    Semin Thromb Hemost; 2002 Apr; 28 Suppl 1():75-8. PubMed ID: 12016582
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current therapy of hemophilia].
    Myllylä G
    Duodecim; 1969; 85(14):850-3. PubMed ID: 5308163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.